Coefficient Bio vs Nimbus Therapeutics
Coefficient Bio vs Nimbus Therapeutics, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Coefficient Bio is on 70/100 and Nimbus Therapeutics on 51/100.
Where each one leads
Coefficient Bio
- our overall score: 70/100 against 51/100
- agent readiness: 46/100 against 27/100
- domain rating: 92/100 against 55/100
- funding raised: $16B against $589M
Nimbus Therapeutics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Coefficient Bio | Nimbus Therapeutics |
|---|---|---|
| What it is | AI safety and research company building reliable, interpretable, and steerable AI systems. | Nimbus Therapeutics is a clinical-stage biotech company using computational drug discovery to develop small molecule medicines. |
| Category | Biotechnology, Artificial Intelligence, Healthcare, Frontier AI Lab | Biotechnology, Drug Discovery, AI, Machine Learning |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Services |
| Founded | 2021 | 2009 |
| Headquarters | San Francisco, United States | Boston, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Coefficient Bio | Nimbus Therapeutics |
|---|---|---|
| Employees | 4,836 | Not published |
| Total funding | $16B | $589M |
| Latest round | Series D | Series F |
| Valuation | $30B | Not published |
| LinkedIn followers | 3,743,477 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Coefficient Bio | Nimbus Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 70/100 | 51/100 |
| Traction | 60/100 | 40/100 |
| Team | Not published | 30/100 |
| Community | 8/100 | 8/100 |
| Search visibility | 38/100 | 18/100 |
| Quality | 97/100 | 70/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (46/100) | F (27/100) |
| Domain ratingLink authority, 0-100 | 92/100 | 55/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Coefficient Bio | Nimbus Therapeutics |
|---|---|---|
| Hosting | Not detected | Google Cloud |
| CDN | Cloudflare | Not detected |
| CMS | Webflow | WordPress |
| Analytics | Not detected | Google Analytics 4, Segment, Microsoft Clarity |
What users say
| Measure | Coefficient Bio | Nimbus Therapeutics |
|---|---|---|
| Reddit sentimentThreads we track | 6 positive, 0 negative across 6 threads | Not published |
“Anthropic buys biotech startup Coefficient Bio in $400M deal: Reports. Anthropic moving further into life sciences and bioinformatics”r/bioinformatics
Coefficient Bio vs Nimbus Therapeutics: common questions
Which is better, Coefficient Bio or Nimbus Therapeutics?
On our 0-100 score Coefficient Bio rates higher (70/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Coefficient Bio and Nimbus Therapeutics compare on the numbers?
Coefficient Bio leads on our overall score (70/100 against 51/100), agent readiness (46/100 against 27/100), domain rating (92/100 against 55/100), funding raised ($16B against $589M).
What do real users say about Coefficient Bio and Nimbus Therapeutics?
Coefficient Bio: 6 positive and 0 negative mentions across 6 Reddit threads we track, mostly in r/bioinformatics.
Read the full Coefficient Bio review and pricing or the Nimbus Therapeutics review and pricing. You can also browse other Coefficient Bio alternatives we track.